Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fasting no Longer Necessary Before Lipid Profile

By HospiMedica International staff writers
Posted on 10 May 2016
A team of international experts recommends that most people do not need to fast before having their cholesterol and triglyceride levels tested.

The joint consensus statement, issued by the European Atherosclerosis Society (EAS; Göteborg, Sweden) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM; Milano, Italy), is based on research from Denmark, Canada, and the United States that combined included over 300,000 people, and which found that cholesterol and triglyceride levels are similar whether a person fasts or not.

According to extensive observational data, the experts concluded that the maximal mean changes one to six hours after habitual meals are not clinically significant for triglycerides, total cholesterol, LDL cholesterol, calculated remnant cholesterol, calculated non-HDL cholesterol, concentrations of HDL cholesterol, apolipoprotein A1, apolipoprotein B, and lipoprotein. More...
In addition, they found that non-fasting and fasting concentrations vary similarly over time, and are comparable in the prediction of cardiovascular disease.

To improve patient compliance with lipid testing, they therefore recommend the routine use of non-fasting lipid profiles, while fasting sampling may be considered when non-fasting triglycerides are higher than 440 mg/dL. For non-fasting samples, laboratory reports should flag abnormal concentrations as triglycerides over 175 mg/dL, total cholesterol over 190 mg/dL, LDL cholesterol over 115 mg/dL, calculated remnant cholesterol over 35 mg/dL, calculated non-HDL cholesterol over 150 mg/dL, HDL cholesterol under 40 mg/dL, apolipoprotein A1 under 125 mg/dL, apolipoprotein B over100 mg/dL, and lipoprotein(a) over 50 mg/dL. The consensus statement was published on April 24, 2106, in European Heart Journal.

“This will improve patients compliance to preventive treatment aimed at reducing number of heart attacks and strokes, the main killers in the world,” says lead author Professor Børge Nordestgaard, MD, of the department of clinical medicine at the University of Copenhagen (KU, Denmark). “We hope that non-fasting cholesterol testing will make more patients together with their doctors implement lifestyle changes, and if necessary statin treatment, to reduce the global burden of cardiovascular disease and premature death.”

In Denmark, the use of random, non-fasting cholesterol testing at any time of the day irrespective of food intake has been used successfully since 2009. Apart from Denmark, all the other countries reviewed require that patients fast for at least eight hours before having a lipid profile to check cholesterol and triglyceride levels.

Related Links:
European Atherosclerosis Society
European Federation of Clinical Chemistry and Laboratory Medicine
University of Copenhagen


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.